Double-blind, Randomised Study of A3384 in BAM/BAD

Bile Acid Malabsorption Clinical Trial

Official title:
A Phase II, Placebo-controlled, Multi-centre, Dose-finding Efficacy and Safety Study of a Range of Doses of A3384 in Patients With Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD)

Status Completed

Clinical Trial Summary

The purpose of this trial is to determine the efficacy and safety of A3384 administered to patients with Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02078856
Study type	Interventional
Source	Ipsen
Contact
Status	Completed
Phase	Phase 2
Start date	March 2014
Completion date	December 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03876717` - Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea	Phase 4
Terminated	`NCT01203254` - Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease	Phase 4
Completed	`NCT02628626` - A Study of Colesevelam in Fecal Incontinence	Phase 3
Completed	`NCT03955575` - Treatment of Bile Acid Malabsorption With Liraglutide	Phase 4
Completed	`NCT03059537` - Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea	Phase 4
Completed	`NCT03168555` - Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy	Phase 4
Recruiting	`NCT05245357` - Impact of Foods on Bile Acids, Metabolites, and Inflammation	N/A
Completed	`NCT03270085` - Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption	Phase 2
Completed	`NCT05130047` - Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)	Phase 2